 | InMed Pharmaceuticals Inc. | |||
| NCM : INM || Location: Canada | ||||
$0.29-0.01 (-3.65%) |
0.06 M | 0.27 - 0.3 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.010 M |
| March 15, 2024 | 0.057 M |
| Feb. 29, 2024 | 0.066 M |
| Feb. 15, 2024 | 0.138 M |
| Jan. 31, 2024 | 0.040 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2022 | -5.50 | -14.03 | -155.10% |
| 03/31/2022 | -6.25 | -6.25 | 0.00% |
| 12/31/2021 | -5.87 | -7.75 | -32.00% |
| 09/30/2021 | -8.75 | -6.25 | 28.60% |
| 06/30/2021 | -8.50 | -10.25 | -20.60% |
INM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 6.059M | Shares Float | 4.844M |
| Short Float | 0.010M | Market Cap | 1.76M |
| Institution ownership | 13.29% | Insider ownership | 1.363% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.42 | Forward EPS | -6.25 |